Evidence map›Paper›PMID 19277062›Full record

ArticleEuropean journal of human genetics : EJHG2009

Goltz-Gorlin (focal dermal hypoplasia) and the microphthalmia with linear skin defects (MLS) syndrome: no evidence of genetic overlap.

May-Britt Harmsen, Silvia Azzarello-Burri, M Mar García González, Gabriele Gillessen-Kaesbach, Peter Meinecke, Dietmar Müller, Anita Rauch, Eva Rossier, Eva Seemanova, Christiane Spaich and 4 more

Open access · bronzeAbstract read
In one paragraph

Article in European journal of human genetics : EJHG, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 39 citations in OpenAlex.

  1. Article
  2. Male Goltz Syndrome due to PostzygoticCase reports in dermatological medicine · 2026
    Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Novel mutation in a child with Goltz syndrome.Indian journal of pediatrics · 2012
    Article
  10. Focal dermal hypoplasia: A novel finding in disguise.Journal of oral biology and craniofacial research
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 12 institutions in 4 countries.

May-Britt HarmsenInstitut für Humangenetik, Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany.
Silvia Azzarello-Burri
M Mar García González
Gabriele Gillessen-Kaesbach
Peter Meinecke
Dietmar Müller
Anita Rauch
Eva Rossier
Eva Seemanova
Christiane Spaich
Bernhard Steiner
Dagmar Wieczorek
Martin Zenker
Kerstin Kutsche
Institut für Forensische Genetik · DEUniversitätsklinikum Erlangen · DEAltonaer Kinderkrankenhaus · DECharles University · CZHospital de FigueresInstitut für Medizinische Informatik, Biometrie und Epidemiologie · DEKlinikum Chemnitz · DEKlinikum Stuttgart · DETH Bingen University of Applied Sciences · DEUniversität Hamburg · DEUniversity Medical Center Hamburg-Eppendorf · DEUniversity of Lübeck · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Focal dermal hypoplasia (FDH) is an X-linked developmental disorder with male lethality characterized by patchy dermal hypoplasia, skeletal and dental malformations, and microphthalmia or anophthalmia. Recently, heterozygous loss-of-function mutations in the PORCN gene have been described to cause FDH. FDH shows some clinical overlap with the microphthalmia with linear skin defects (MLS) syndrome, another X-linked male lethal condition, associated with mutations of HCCS in the majority of cases. We performed DNA sequencing of PORCN in 13 female patients with the clinical diagnosis of FDH as well as four female patients with MLS syndrome and no mutation in HCCS. We identified PORCN mutations in all female patients with FDH. Eleven patients seem to have constitutional PORCN alterations in the heterozygous state and two individuals are mosaic for the heterozygous sequence change in PORCN. No PORCN mutation was identified in the MLS-affected patients, providing further evidence that FDH and MLS do not overlap genetically. X chromosome inactivation (XCI) analysis revealed a random or slightly skewed XCI pattern in leukocytes of individuals with intragenic PORCN mutation suggesting that defective PORCN does not lead to selective growth disadvantage, at least in leukocytes. We conclude that the PORCN mutation detection rate is high in individuals with a clear-cut FDH phenotype and somatic mosaicism can be present in a significant proportion of patients with mild or classic FDH.

Indexed as

AcyltransferasesAlternative SplicingChild, PreschoolChromosomes, Human, XDNA Mutational AnalysisFemaleFocal Dermal HypoplasiaGenes, X-LinkedHumansMaleMembrane ProteinsMicrophthalmosModels, GeneticMutationPhenotypePolymorphism, Single NucleotideAcyltransferasesMembrane ProteinsPORCN protein, human

Identifiers

PMID19277062
PMCPMC2986635
OpenAlexW1990766457

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.